Cargando…

KAT5 histone acetyltransferase mutations in cancer cells

Cancer cells are characterized by accumulation of mutations due to improperly repaired DNA damage. The DNA double strand break is one of the most severe form of damage and several redundant mechanisms have evolved to facilitate accurate repair. During DNA replication and in mitosis, breaks are prima...

Descripción completa

Detalles Bibliográficos
Autores principales: L Hardison, Kimberly, M Hawk, Tila, A Bouley, Renee, C Petreaca, Ruben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Caltech Library 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748724/
https://www.ncbi.nlm.nih.gov/pubmed/36530474
http://dx.doi.org/10.17912/micropub.biology.000676
_version_ 1784849886891474944
author L Hardison, Kimberly
M Hawk, Tila
A Bouley, Renee
C Petreaca, Ruben
author_facet L Hardison, Kimberly
M Hawk, Tila
A Bouley, Renee
C Petreaca, Ruben
author_sort L Hardison, Kimberly
collection PubMed
description Cancer cells are characterized by accumulation of mutations due to improperly repaired DNA damage. The DNA double strand break is one of the most severe form of damage and several redundant mechanisms have evolved to facilitate accurate repair. During DNA replication and in mitosis, breaks are primarily repaired by homologous recombination which is facilitated by several genes. Key to this process is the breast cancer susceptibility genes BRCA1 and BRCA2 as well as the accessory RAD52 gene. Proper chromatin remodeling is also essential for repair and the KAT5 histone acetyltransferase facilitates histone removal at the break. Here we undertook a pan cancer analysis to investigate mutations within the KAT5 gene in cancer cells. We employed two standard artificial algorithms to classify mutations as either driver (CHASMPlus algorithm) or pathogenic (VEST4 algorithm). We find that most predicted driver and disease-causing mutations occur in the catalytic site or within key regulatory domains. In silico analysis of protein structure using AlphaFold shows that these mutations are likely to destabilize the function of KAT5 or interactions with DNA or its other partners. The data presented here, although preliminary, could be used to inform clinical strategies.
format Online
Article
Text
id pubmed-9748724
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Caltech Library
record_format MEDLINE/PubMed
spelling pubmed-97487242022-12-15 KAT5 histone acetyltransferase mutations in cancer cells L Hardison, Kimberly M Hawk, Tila A Bouley, Renee C Petreaca, Ruben MicroPubl Biol New Finding Cancer cells are characterized by accumulation of mutations due to improperly repaired DNA damage. The DNA double strand break is one of the most severe form of damage and several redundant mechanisms have evolved to facilitate accurate repair. During DNA replication and in mitosis, breaks are primarily repaired by homologous recombination which is facilitated by several genes. Key to this process is the breast cancer susceptibility genes BRCA1 and BRCA2 as well as the accessory RAD52 gene. Proper chromatin remodeling is also essential for repair and the KAT5 histone acetyltransferase facilitates histone removal at the break. Here we undertook a pan cancer analysis to investigate mutations within the KAT5 gene in cancer cells. We employed two standard artificial algorithms to classify mutations as either driver (CHASMPlus algorithm) or pathogenic (VEST4 algorithm). We find that most predicted driver and disease-causing mutations occur in the catalytic site or within key regulatory domains. In silico analysis of protein structure using AlphaFold shows that these mutations are likely to destabilize the function of KAT5 or interactions with DNA or its other partners. The data presented here, although preliminary, could be used to inform clinical strategies. Caltech Library 2022-11-28 /pmc/articles/PMC9748724/ /pubmed/36530474 http://dx.doi.org/10.17912/micropub.biology.000676 Text en Copyright: © 2022 by the authors https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle New Finding
L Hardison, Kimberly
M Hawk, Tila
A Bouley, Renee
C Petreaca, Ruben
KAT5 histone acetyltransferase mutations in cancer cells
title KAT5 histone acetyltransferase mutations in cancer cells
title_full KAT5 histone acetyltransferase mutations in cancer cells
title_fullStr KAT5 histone acetyltransferase mutations in cancer cells
title_full_unstemmed KAT5 histone acetyltransferase mutations in cancer cells
title_short KAT5 histone acetyltransferase mutations in cancer cells
title_sort kat5 histone acetyltransferase mutations in cancer cells
topic New Finding
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748724/
https://www.ncbi.nlm.nih.gov/pubmed/36530474
http://dx.doi.org/10.17912/micropub.biology.000676
work_keys_str_mv AT lhardisonkimberly kat5histoneacetyltransferasemutationsincancercells
AT mhawktila kat5histoneacetyltransferasemutationsincancercells
AT abouleyrenee kat5histoneacetyltransferasemutationsincancercells
AT cpetreacaruben kat5histoneacetyltransferasemutationsincancercells